NovaRad gets FDA nod for NovaPACS for mammography use
NovaRad Corporation announces that the U.S. Food and Drug Administration (FDA) has issued clearance of its NovaPACS for reading and interpreting mammography studies. NovaPACS uses the DICOM standard for the distribution and viewing of mammography studies including window/level/zoom, as well as volumetric measurements. NovaPACS is a complete, enterprise-level PACS. The company also provides the approved 5 MpiLCD monitors for reading, according to a release.